"The CAR-T Therapy Tisagenlecleucel Is Safe in Secondary CNS Lymphoma."

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Tisagenlecleucel has an acceptable safety profile and showed preliminary evidence of CNS efficacy. Click to show full abstract

Tisagenlecleucel has an acceptable safety profile and showed preliminary evidence of CNS efficacy.

Keywords: safe secondary; cns; car therapy; tisagenlecleucel; tisagenlecleucel safe; therapy tisagenlecleucel

Journal Title: Cancer discovery
Year Published: 2019

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
1

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended